Anna Dumitriu (1969) is a British artist who works with BioArt, sculpture, installation, and digital media to explore our relationship to infectious diseases, synthetic biology and robotics. She has an extensive international exhibition profile including ZKM, Ars Electronica, BOZAR, The Picasso Museum, The V & A Museum Philadelphia Science Center, The Museum of Contemporary Art Taipei LABoral, Art Laboratory Berlin, and The Museum of the History of Science.
She was the 2018 President of the Science and the Arts section of the British Science Association. Her work is held in several major public collections, including the Science Museum London and Eden Project.
Dumitriu is a renowned speaker and has presented talks on her work at prestigious venues including TATE Modern, Princeton University, Imperial College London, The University of Oxford, La Musee de la Chasse et de la Nature, and UCLA.
Her work is featured in many books including Bio Art: Altered Realities published by Thames and Hudson in 2016 and many other significant publications across contemporary art and science including Frieze, Artforum International Magazine, Leonardo Journal, The Art Newspaper, Art Quarterly, Nature and The Lancet.
She holds visiting research fellowships at the University of Hertfordshire, Brighton and Sussex Medical School, and Waag Society, as well as artist-in-residence roles with the Modernising Medical Microbiology Project at the University of Oxford, and with the National Collection of Type Cultures at Public Health England. Her current collaborations also include “Biotechnology from the Blue Flower” with the EU H2020 CHIC Consortium exploring new plant breeding methods and CRISPR, and “Fermenting Futures” focussed on yeast biotechnology in collaboration with the Institute of Microbial Biotechnology at BOKU in Vienna. She recently completed her “Cyberspecies Proximity” project with Schindler as part of an EU Vertigo STARTS residency exploring the futures of robotics.
She has worked with the Liu Laboratory for Synthetic Evolution at The University of California in Irvine (USA) to explore synthetic biology and the resulting artworks were featured in the ground-breaking exhibition “WETWARE” at the Beall Center for Art and Technology in Irvine (USA) curated by Jens Hauser and David Familian. Notably she also worked with the MRG-Grammar project to create artworks using CRISPR gene editing technology and collaborating with BeyondSeq at the University of Birmingham to explore the biochemistry of DNA.
Dumitriu was lead artist on the Creative Europe supported project “Trust Me, I’m an Artist” which investigates the novel ethical problems that arise when artists create artwork in laboratory settings. Her book of the same name, co-authored with Professor Bobbie Farsides, was published in 2014. She is also the founder and director of “The Institute of Unnecessary Research“, a group of artists and scientists whose work crosses disciplinary boundaries and critiques contemporary research practice. In 2012 Dumitriu received the Society for Applied Microbiology Communication Award.
Support Anna Dumitriu’s valuable work on Patreon from just $1 per month.
Grateful thanks to The Infection Prevention Strategy for their ongoing support.
Social Media Links
Follow @annadumitriu on Twitter
Follow Anna Dumitriu on Instagram
Friend/Follow Anna Dumitriu on Facebook
Like Anna Dumitriu’s Facebook Page
Connect with Anna Dumitriu on LinkedIn
Selected Supporters and Funders
Grateful thanks to Arts Council England, Creative Europe, EU Horizon 2020, The Leverhulme Trust, The Wellcome Trust, The Royal College of Pathologists, and The University of Oxford Seed Fund.
The FEAT Residency Project – FEAT is funded by the EU backed programme FET (Future and Emerging Technologies) Open. It has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 686527 (H2020-‐FETOPEN-‐2015-‐CSA)
The Hunt for New Antimicrobials project – funded through the Artist in Residence Scheme 2016 of the Centre for Chronic Diseases and Disorders (C2D2) at the University of York. The scheme is supported by the Wellcome Trust [ref: 105624] and the University of York.